De novo lipogenesis as a therapeutic target

Inhibition of the de novo lipogenesis established the connections between the role of the onco-metabolic pathway regulating diverse cell survival processes which suggest targeting these marker enzymes can be of great use in terms of CAC diagnosis, treatment, and further management. In this study we have tried to monitor the prime enzymes of the lipogenesis process and investigated their importance in cancer development and metastasis.